Month: September 2020

Inhibiting or stopping the formation of platelet aggregation. Destructive to platelets. A pharmaceutical agent that diminishes or eradicates the functionality of platelets responsible for blood clotting, commonly employed as a preventive measure against strokes.  

Protect body cells from the damaging effects of oxidation.  

Directed or effective against an enzyme (hyaluronidase) that breaks down hyaluronic acid, thus facilitating the spread of fluid through tissues.  

Counteracting the effects of a poison.  

An agent that prevents or relieves seizures or epileptic attack. Drugs most commonly used for the treatment of seizures. Anticonvulsants also may be effective in preventing or treating mania and depression in patients with bipolar disorder, hence their other name, mood stabilizers. They are used to treat refractory depression as well. An agent that reduces…

Describing an agent that will stop the formation of a cancer. Tending to delay or prevent tumor formation.  

Reducing the frequency or rate of uncontrolled cell growth. Used in the treatment of cancer, esp. anticancer drugs (e.g., vincristine sulfate).  

Preventing genetically programmed cell death.  

Allaying anxiety; Calms anxiety. An agent employed to alleviate the symptoms of anxiety, which could entail emotions of dread, unease, or nervousness, typically achieved by administering a sedative or a mild tranquilizer.  

Hyperaldosteronism; an abnormality of electrolyte balance caused by excessive secretion of aldosterone. A condition in which a person produces too much aldosterone, so that there is too much salt in the blood. This causes high blood pressure and the need to drink a lot of liquids. A condition in which the adrenal cortex (the outer…